Search Results - "Buhler, Anima"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease by Bühler, Anima D, Bucher, Felicitas, Augustynik, Michael, Wöhrl, Jan, Martin, Gottfried, Schlunck, Günther, Agostini, Hansjürgen, Böhringer, Daniel, Pütz, Gerhard, Stahl, Andreas

    Published in BMC ophthalmology (05-09-2016)
    “…Omega-3 polyunsaturated fatty acids (PUFAs) have a highly anti-angiogenic effect in animal models. However, the clinical relevance of omega-3PUFAs in human…”
    Get full text
    Journal Article
  2. 2

    Retrobulbar Optic Nerve Diameter Measured by High-Speed Magnetic Resonance Imaging as a Biomarker for Axonal Loss in Glaucomatous Optic Atrophy by Lagreze, Wolf A, Gaggl, Mirjam, Weigel, Matthias, Schulte-Monting, Jurgen, Buhler, Anima, Bach, Michael, Munk, Robin D, Bley, Thorsten A

    “…To assess a novel magnetic resonance imaging (MRI) protocol for quantifying the optic nerve diameter (OND) as a measure of axonal loss in the optic nerve…”
    Get full text
    Journal Article
  3. 3

    Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival by Reuer, Tristan, Schneider, Ann-Charlott, Cakir, Bertan, Bühler, Anima D, Walz, Johanna M, Lapp, Thabo, Lange, Clemens, Agostini, Hansjürgen, Schlunck, Günther, Cursiefen, Claus, Reinhard, Thomas, Bock, Felix, Stahl, Andreas

    “…Corneal vascularization significantly increases the risk for graft rejection after keratoplasty. Semaphorin 3F (Sema3F) is a known modulator of physiologic…”
    Get full text
    Journal Article
  4. 4

    OCT Angiography of the Choriocapillaris in Central Serous Chorioretinopathy: A Quantitative Subgroup Analysis by Cakir, Bertan, Reich, Michael, Lang, Stefan, Bühler, Anima, Ehlken, Christoph, Grundel, Bastian, Stech, Milena, Reichl, Sabine, Stahl, Andreas, Böhringer, Daniel, Agostini, Hansjürgen, Lange, Clemens

    Published in Ophthalmology and therapy (01-03-2019)
    “…Introduction To quantify optical coherence tomography angiography (OCTA) signal changes at the level of the choriocapillaris (CC) in patients with different…”
    Get full text
    Journal Article
  5. 5

    Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa by Ness, Thomas, Böhringer, Daniel, Heinzelmann, Sonja Ute, Bühler, Anima Desiree, Pielen, Amelie, Junker, Bernd

    Published in Journal of ophthalmology (01-01-2017)
    “…Purpose. To evaluate the anatomical and functional outcome of intravitreal dexamethasone implant for macular edema secondary to central (C) or branch (B)…”
    Get full text
    Journal Article
  6. 6

    Sema3f Protects Against Subretinal Neovascularization In Vivo by Sun, Ye, Liegl, Raffael, Gong, Yan, Bühler, Anima, Cakir, Bertan, Meng, Steven S., Burnim, Samuel B., Liu, Chi-Hsiu, Reuer, Tristan, Zhang, Peipei, Walz, Johanna M., Ludwig, Franziska, Lange, Clemens, Agostini, Hansjürgen, Böhringer, Daniel, Schlunck, Günther, Smith, Lois E.H., Stahl, Andreas

    Published in EBioMedicine (01-04-2017)
    “…Pathological neovascularization of the outer retina is the hallmark of neovascular age-related macular degeneration (nAMD). Building on our previous…”
    Get full text
    Journal Article
  7. 7

    Intra- and postoperative risks and complications of small-gauge (23-G) versus conventional (20-G) vitrectomy for macular surgery by Pielen, Amelie, Guerra, Nuria I Pérez, Böhringer, Daniel, Junker, Bernd, Bühler, Anima D, Stahl, Andreas, Agostini, Hansjürgen T, Ehlken, Christoph

    Published in European journal of ophthalmology (01-09-2014)
    “…To compare the complication spectrum and rate of 23-G and 20-G vitrectomy for macular surgery. This was a retrospective comparative analysis of 20-G and 23-G…”
    Get full text
    Journal Article
  8. 8

    Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV by Wecker, Thomas, Ehlken, Christoph, Bühler, Anima, Lange, Clemens, Agostini, Hansjürgen, Böhringer, Daniel, Stahl, Andreas

    Published in British journal of ophthalmology (01-03-2017)
    “…Anti vascular endothelial growth factor (VEGF) therapy is an established treatment for various retinal diseases. Long-term data on injection frequencies and…”
    Get more information
    Journal Article
  9. 9

    Clinical experience with eplerenone to treat chronic central serous chorioretinopathy by Cakir, Bertan, Fischer, Franziska, Ehlken, Christoph, Bühler, Anima, Stahl, Andreas, Schlunck, Günther, Böhringer, Daniel, Agostini, Hansjürgen, Lange, Clemens

    “…Purpose Chronic central serous chorioretinopathy (CSC) is a vision-threatening eye disease for which there is still no approved treatment. Recent studies…”
    Get full text
    Journal Article
  10. 10
  11. 11